Robert Scott  Goodman net worth and biography

Robert Goodman Biography and Net Worth

CEO of Beyond Air

Robert Goodman assumed CEO position in March 2026. Mr. Goodman is a seasoned healthcare executive and board director with a distinguished track record of leadership across the medical technology and pharmaceutical industries. He joined the Board of Beyond Air in June 2025 and served as Chief Commercial Officer from November 2025 to March 2026 where he led a rapid transformation of the business strategy, grounded in technology, process and people, positioning the business for scalable and sustainable growth. He brings decades of experience guiding companies through rapid growth and global expansion consistently exceeding stakeholder expectations including multiple successful exits.

Mr. Goodman has held key leadership roles at a range of high-performing organizations, including BioTelemetry, Philips Healthcare, Cardiocore, Thermo Fisher Scientific, and Pfizer. Spanning public companies, private equity–backed businesses, and early-stage ventures, he has consistently driven innovation, operational scale, and commercial success.

Known for his ability to lead international teams and navigate complex healthcare markets, Mr. Goodman is also a board member at Fourth Frontier, a wearable health tech company.

A retired U.S. Army officer, Mr. Goodman earned his degree from Norwich University and brings the discipline and strategic mindset developed during his military career to his leadership in the private sector.

What is Robert Scott Goodman's net worth?

The estimated net worth of Robert Scott Goodman is at least $77.30 thousand as of July 29th, 2026. Goodman owns 34,822 shares of Beyond Air stock worth more than $77,305 as of October 9th. This net worth evaluation does not reflect any other assets that Goodman may own. Learn More about Robert Scott Goodman's net worth.

How do I contact Robert Scott Goodman?

The corporate mailing address for Goodman and other Beyond Air executives is 900 Stewart Avenue, Suite 301, Garden City, NY, 11530. Beyond Air can also be reached via phone at (516) 665-8200 and via email at [email protected]. Learn More on Robert Scott Goodman's contact information.

Has Robert Scott Goodman been buying or selling shares of Beyond Air?

Robert Scott Goodman has not been actively trading shares of Beyond Air during the last ninety days. Most recently, on Wednesday, July 29th, Robert Scott Goodman bought 34,722 shares of Beyond Air stock. The stock was acquired at an average cost of $5.76 per share, with a total value of $199,998.72. Following the completion of the transaction, the chief executive officer now directly owns 34,822 shares of the company's stock, valued at $200,574.72. Learn More on Robert Scott Goodman's trading history.

Who are Beyond Air's active insiders?

Beyond Air's insider roster includes Amir Avniel (COO), Douglas Beck (CFO), Ron Bentsur (Director), Robert Carey (Director), Michael Gaul (COO), Robert Goodman (CEO), Steven Lisi (CEO), Erick Lucera (Director), and Daniel Moorhead (CFO). Learn More on Beyond Air's active insiders.

Are insiders buying or selling shares of Beyond Air?

In the last year, Beyond Air insiders bought shares 2 times. They purchased a total of 39,062 shares worth more than $224,997.12. The most recent insider tranaction occured on July, 29th when CEO Robert Scott Goodman bought 34,722 shares worth more than $199,998.72. Insiders at Beyond Air own 10.0% of the company. Learn More about insider trades at Beyond Air.

Information on this page was last updated on 7/29/2026.

Robert Scott Goodman Insider Trading History at Beyond Air

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/29/2026Buy34,722$5.76$199,998.7234,822View SEC Filing Icon  
See Full Table

Robert Scott Goodman Buying and Selling Activity at Beyond Air

This chart shows Robert Scott Goodman's buying and selling at Beyond Air by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Beyond Air Company Overview

Beyond Air logo
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Read More

Today's Range

Now: $2.25
Low: $2.20
High: $2.34

50 Day Range

MA: $4.13
Low: $2.31
High: $6.92

2 Week Range

Now: $2.25
Low: $2.20
High: $55.00

Volume

64,289 shs

Average Volume

198,017 shs

Market Capitalization

$2.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21